This story was first published in digitalhealth.net
Green light for blood cancer drug
IMNOVID or Pomalidomide, a drug which has been used to help treat patients will blood cancers in Scotland, Wales and Ireland has been given the green light for use in England.
The drug is used to treat multiple myeloma, an incurable disease and the biggest blood cancer killer in the UK.
The, news comes after Pomalidomide was removed from the Cancer Drugs Fund in 2015, but will now be available to all UK patients who qualify.
This brings England in line with the rest of the UK and Europe, where this treatment has been a standard of care for years.
The news has bee welcomed by the clinical community and the multiple myeloma patients, whereby the blood cancer usually requires a different treatment option at every stage of disease.
Dr. Kevin Boyd, Consultant Haematologist at The Royal Marsden Hospital commented: “Pomalidomide is an important treatment for people affected by late stage multiple myeloma; we know that it is an effective medicine and can be taken by patients long term. It is very reassuring that the medicine will be available to patients as the only National Institute for Health and Care Excellence (NICE) approved treatment at this stage of the disease.
Latest News
16/02/2024 - 12:56
Hammersmith and Fulham Council has created a new alliance intended to clean dirty air and improve residents' health.
16/02/2024 - 10:44
Two million more GP appointments a month are being delivered for patients compared to the same month before the pandemic as part of the NHS primary care access recovery plan according to new NHS data.
15/02/2024 - 10:26
The Welsh Government has provided innovation funding of £380,000 to support two projects utilising technology in domiciliary care.
15/02/2024 - 10:13
The new Scottish health secretary has met with frontline staff at Queen Elizabeth University Hospital in Glasgow.
14/02/2024 - 10:27
The North East London NHS Foundation Trust (NELFT) has appointed three new Executive Directors to the Trust Board.
Product Features
UK Building Regulations highlight toxic gas and smoke from layers of paint built up over multiple redecorations as a major cause of permanent ill health or death in a building fire.
Their concern rose with discovery the flame retardant paints most widely used paint along escape routes have been ones which to this day counter-productively use emission of heavy toxic gas to smother flames which rapidly spread along walls if layers of paint delaminate in a fire.
Supplier Profiles
Northwich’s Victoria Infirmary (VIN) Community Diagnostic Centre (CDC) has enabled more patients
Adveco, the commercial hot water specialist, announces the launch of live metering of domestic ho
Latest Features
Sarah Greenslade, public affairs and communications officer at the British Parking Association looks at some of the problems and innovations in healthcare parking
It’s easy to assume that the comms team is there to handle press enquiries and the occasional social media storm – but the reality is that strategic communications can make a measurable impact across the entire organisation, from operational to financial, when done properly
